Economic Overview - The Consumer Price Index (CPI) report for December indicates a stabilizing inflation picture in the U.S., suggesting a potential for interest rate cuts in 2026 [1] - The strong start to the fourth-quarter earnings season and ongoing AI momentum have positively influenced U.S. equities as they enter 2026 [1] Investment Strategy - Investors are encouraged to create a winning stock portfolio to capitalize on the favorable market conditions, although selecting outperformers can be challenging due to market complexities [2] - Expert advice from brokers is essential for individual investors to navigate the stock market effectively [3] Broker Recommendations - Brokers favor stocks such as Cardinal Health (CAH), AutoNation (AN), American Airlines (AAL), ArcBest Corporation (ARCB), and Asbury Automotive Group (ABG) due to net analyst upgrades and upward earnings revisions [8] - These stocks are highlighted amid easing inflation and a strong kickoff to Q4 earnings [8] Screening Criteria for Stocks - A screening strategy has been developed to identify stocks based on improving analyst recommendations and upward revisions in earnings estimates over the last four weeks [5] - Key criteria include a low price/sales ratio, significant trading volume, and a market capitalization ranking within the top 3000 [6][9] Company Highlights - **Cardinal Health (CAH)**: A leading healthcare services provider with a projected revenue growth of 16.2% year-over-year for fiscal 2026 and a long-term earnings growth rate of 13.9% [10] - **AutoNation (AN)**: A major automotive retailer expanding its dealer network and digital capabilities, with a 0.4% upward revision in 2026 earnings estimates [12] - **American Airlines (AAL)**: Benefiting from increased air travel demand, but facing challenges from high labor costs and debt levels, with a 7.5% upward revision in earnings estimates [13] - **ArcBest (ARCB)**: A freight transportation company expecting a 42.3% increase in earnings per share for 2026, despite mixed earnings performance in recent quarters [14] - **Asbury Automotive Group (ABG)**: A diversified auto retailer with a focus on digital solutions, achieving an average earnings beat of 8.4% over the last four quarters [15][16]

WOONSOCKET, R.I., Jan. 15, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Tuesday, February 10, 2026, at 8:00 a.m. ET to discuss fourth quarter and full year 2025 financial results. An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for a period of one year. About CVS Health CVS Health is a leading health solutions company build ...

NEW YORK, Jan. 15, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of agilon health, inc. (NYSE: AGL). Shareholders who purchased shares of AGL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/agilon-health-inc-loss-submission-form/?id=183126&from=4 CLASS PERIOD: February 26, 2 ...

NEW YORK, Jan. 15, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Ardent Health, Inc. (NYSE: ARDT). Shareholders who purchased shares of ARDT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/ardent-health-inc-loss-submission-form/?id=183129&from=4 CLASS PERIOD: July 18, 202 ...

Despite being a growth investor, I don't always invest in healthcare companies. When it comes to the pharma sector, especially, I am very cautious given regulatory uncertainties and the difficulty in predicting the outcomes of clinical trials. However, there are other types of healthcare companies thatDilantha De Silva is an experienced equity analyst and investment researcher with over 10 years in the investment industry. He writes insightful articles for Seeking Alpha, GuruFocus, TipRanks, and ValueWalk, ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for alleged violations of the Securities Exchange Act, specifically for making false and misleading statements regarding its financial reporting [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from July 18, 2024, to November 12, 2025, with a deadline for lead plaintiff appointments set for March 9, 2026 [2]. - The complaint alleges that Ardent Health utilized a 180-day cliff on accounts receivable, allowing the company to report inflated amounts and delay loss recognition, rendering its public statements materially misleading [2]. Group 2: Investor Participation - Shareholders who purchased shares during the class period are encouraged to contact the law firm for potential lead plaintiff appointments, although such an appointment is not necessary to participate in any recovery [2][3].

NEW ORLEANS, Jan. 14, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until March 9, 2026 to file lead plaintiff applications in a securities class action lawsuit against Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE: ARDT), if they purchased or otherwise acquired the Company’s securities between July 18, 2024 and November 12, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the Middle ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Agilon Health, Inc. regarding a class action lawsuit due to alleged misleading statements and guidance issued by the company during a specified period [1][3]. Group 1: Allegations - The complaint alleges that Agilon Health's defendants issued materially false and/or misleading statements and failed to disclose critical information during the class period from February 26, 2025, to August 4, 2025 [3]. - Specific allegations include that the defendants recklessly provided guidance for 2025 that they knew or should have known was unattainable due to significant industry challenges [3]. - Additionally, it is claimed that the defendants overstated the immediate positive financial impact from strategic actions taken to mitigate risk, leading to materially false and misleading statements about the company's business and prospects [3]. Group 2: Class Action Details - Shareholders who purchased shares of Agilon Health during the class period are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for March 2, 2026 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress [4]. - Participation in the case incurs no cost or obligation for the shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit, fraud, and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [5].

PresentationPresenting for the company will be Jim Boyle, their CEO. Mike Drazin, their CFO, is going to join us for the Q&A portion. But before we get started, Karen King, who is Head of Investor Relations, is just going to read an opening reg FDC.All right. Great. Good afternoon, everyone, and welcome. My name is Lisa Gill, and I head up health care services here at JPMorgan. It is with great pleasure this afternoon that I introduce Medline for their first JPMorgan Healthcare Conference as a publicly trad ...